Overcoming alcohol use disorder can be challenging. But drugs like Librium can help treat uncomfortable withdrawal symptoms.

Librium is used for alcohol withdrawal because it can reduce withdrawal symptoms and lower the risk of dangerous complications when someone suddenly stops or cuts back after heavy alcohol use. 

Alcohol withdrawal can cause anxiety, tremors, sweating, nausea, insomnia, agitation, hallucinations, seizures and delirium tremens. Librium, the well-known brand name for chlordiazepoxide, is a long-acting benzodiazepine that helps calm nervous system overactivity during supervised withdrawal care (Canver et al., 2024; Ahwazi et al., 2024).

Librium should only be used under clinical guidance. It can cause sedation, confusion, poor coordination, dependence and overdose, especially when mixed with opioids, sleep medicines or other sedatives. For many patients, the safest setting is a monitored program where clinicians can check vital signs, sedation level and seizure risk (ASAM, 2020; U.S. National Library of Medicine, 2025).

Free, Confidential Helpline

Ready to take the next step toward recovery?

Our Recovery Advocates are available around the clock to answer your questions, verify your insurance, and help you find the right level of care — at no cost to you.

Call Us Now

(360) 857-0007

Available 24 hours a day, 7 days a week

Key Takeaways

  • Yes, Librium helps manage the short-term withdrawal syndrome, but it does not treat addiction long term. After stabilization, ongoing care may include therapy, relapse prevention, rehab, recovery support and FDA-approved options such as naltrexone, acamprosate or disulfiram (NIAAA, n.d.; SAMHSA, 2025).
  • Librium is chlordiazepoxide, a long-acting benzodiazepine used to reduce withdrawal symptoms such as tremors, anxiety, agitation and insomnia (Ahwazi et al., 2024).
  • Benzodiazepines are first-line medications for many patients at risk of severe AWS, including seizures or delirium tremens (ASAM, 2020).
  • Severe alcohol withdrawal can include seizures, hallucinations, confusion, high blood pressure, irregular heartbeat and delirium tremens. Seizures may occur 6–48 hours after the last drink, and delirium tremens often begins 48–72 hours after stopping (Jesse et al., 2016).
  • Dosing is not one-size-fits-all. DailyMed lists acute alcohol withdrawal dosing as 50–100 mg initially, repeated as needed up to 300 mg per day, then reduced after agitation is controlled; this is prescribing-label information, not self-dosing guidance (U.S. National Library of Medicine, 2025).
  • Do not mix Librium with opioids, sleep medicines or other sedatives. Combining benzodiazepines with opioids can cause profound sedation, respiratory depression, coma and death (U.S. National Library of Medicine, 2025).
  • At-home care may be unsafe for people with prior seizures, delirium tremens, heavy daily drinking, severe symptoms, unstable health, pregnancy, polysubstance use or limited support; higher-risk cases often need inpatient monitoring (ASAM, 2020).

The Direct Answer: How Librium Helps During Detox

Librium helps make alcohol withdrawal safer and more manageable by calming the brain and nervous system. When someone drinks heavily over time, the brain adapts to alcohol’s sedating effects. When alcohol use suddenly stops, the brain can become overstimulated, leading to tremors, anxiety, sweating, insomnia, agitation, high blood pressure, rapid heart rate, seizures or delirium tremens (Canver et al., 2024; Jesse et al., 2016).

The medication helps reduce this overstimulation during acute withdrawal. Its purpose is to control symptoms, support prevention of severe complications and help the person stabilize. It does not remove alcohol from the body, cure alcohol abuse or replace long-term addiction treatment.

Who May Need Medication Support?

A person may need chlordiazepoxide therapy or another withdrawal management option if symptoms are moderate to severe or if they are at higher risk for complications. A doctor should make this decision after reviewing the person’s alcohol use history, current symptoms, health conditions and use of other substances. ASAM recommends matching the care setting and medication plan to the person’s severity, risk factors and monitoring needs (ASAM, 2020).

Medication support may be considered for people who have:

  • Shaking or tremors
  • Severe anxiety or agitation
  • Sweating
  • Insomnia
  • Rapid heart rate
  • High blood pressure
  • Nausea or vomiting
  • Prior seizures during withdrawal
  • Prior delirium tremens
  • Heavy daily alcohol use
  • Repeated withdrawal episodes
  • Risk of worsening symptoms during stabilization

Not everyone needs Librium. Some people may need a different medication, a different benzodiazepine, inpatient care or hospital support depending on their health risk level (ASAM, 2020).

When Alcohol Withdrawal Symptoms Become Dangerous

Alcohol withdrawal can be life-threatening. Get medical help immediately if symptoms are severe, worsening or connected to a history of complicated withdrawal.

Emergency warning signs may include:

  • Seizures
  • Confusion
  • Hallucinations
  • Severe agitation
  • Fever
  • Severe vomiting
  • Chest pain
  • Fainting
  • Dehydration
  • Very high blood pressure
  • Irregular heartbeat
  • Delirium tremens
  • Loss of consciousness

A person should also seek supervised care if they have had seizures or delirium tremens before, drink heavily every day, use benzodiazepines or opioids, have serious medical conditions, are pregnant or have thoughts of self-harm. Delirium tremens is one of the most severe forms of the withdrawal syndrome and requires prompt recognition and management (Kaye et al., 2024).

Chlordiazepoxide Basics

Librium is the well-known brand name for chlordiazepoxide, a benzodiazepine medication. Although the original brand-name version has been discontinued, the generic form is still available, and many people still refer to it by the older brand name.

Benzodiazepines slow activity in the central nervous system. During alcohol withdrawal, this can help reduce anxiety, agitation, tremors, insomnia and seizure risk. Librium may also be prescribed for anxiety or short-term relief of acute agitation when a clinician determines it is appropriate (Ahwazi et al., 2024).

Librium is long-acting, meaning its effects last longer than some shorter-acting benzodiazepines. That can be helpful because symptoms can rise and fall over several days.

Why Doctors Use Benzodiazepines During Detox

Benzodiazepines are used because they can control symptoms and help prevent serious complications during the acute withdrawal period. ASAM’s alcohol withdrawal guideline recommends benzodiazepines as first-line medication for many patients at risk of severe or complicated alcohol withdrawal (ASAM, 2020).

Clinicians may choose Librium because it:

  • Belongs to a medication class commonly used for withdrawal management
  • Can reduce agitation, tremors and anxiety
  • Can help lower seizure risk
  • Lasts longer than some shorter-acting benzodiazepines
  • May reduce breakthrough symptoms between doses
  • Can be adjusted based on severity

It is not used because it “sobers someone up.” It is used to manage withdrawal safely while the body adjusts to the absence of alcohol.

How It Works in the Brain

Librium affects GABA, a calming neurotransmitter that helps slow brain activity. Heavy alcohol use can affect this system, which is one reason the brain may become dependent on alcohol’s sedating effects (Dharavath et al., 2023).

When someone stops heavy alcohol use, calming activity may be too low and excitatory activity may be too high. This imbalance can lead to withdrawal symptoms. The medication enhances inhibitory effects in the brain, which can reduce the overactivity that makes alcohol withdrawal dangerous (Ahwazi et al., 2024).

This is why it may help with tremors, anxiety, agitation, sweating, insomnia, fast heart rate, elevated blood pressure, restlessness and seizure risk.

Withdrawal Syndrome and Symptoms It May Help Treat

Librium may be used to manage mild, moderate or severe withdrawal symptoms depending on the person’s risk level and care setting. Alcohol withdrawal symptoms can range from mild anxiety and tremor to severe complications such as seizures and delirium tremens (Canver et al., 2024).

Symptoms may include:

  • Anxiety
  • Shaking or tremors
  • Sweating
  • Nausea
  • Vomiting
  • Headache
  • Insomnia
  • Irritability
  • Agitation
  • Rapid heart rate
  • High blood pressure
  • Sensitivity to light or sound
  • Confusion
  • Hallucinations
  • Seizures
  • Delirium tremens

A clinician should decide whether this medication is appropriate based on symptoms, risk factors, health history and overall condition.

Dosage and Safety

There is no single dose that is right for everyone. Dosing depends on severity, alcohol use history, age, liver function, other medications, vital signs, sedation level and risk for seizures or delirium tremens.

In supervised care, Librium may be given using a symptom-triggered approach. This means the care team checks symptoms regularly and gives medication based on the person’s current condition. Many programs use a scale such as CIWA-Ar to help guide decisions (ASAM, 2020).

A clinician may adjust dosing based on:

  • Tremor severity
  • Sweating
  • Anxiety
  • Agitation
  • Nausea or vomiting
  • Hallucinations
  • Headache
  • Orientation and confusion
  • Blood pressure
  • Heart rate
  • Sedation level
  • Seizure risk

DailyMed’s chlordiazepoxide label lists oral dosing for acute alcohol withdrawal as an initial 50–100 mg, followed by repeated doses as needed until agitation is controlled, up to 300 mg per day, before reducing to maintenance levels. This is prescribing-label information, not self-dosing guidance. Taking too much can cause dangerous sedation, confusion, falls, slowed breathing or overdose (U.S. National Library of Medicine, 2025).

What Is CIWA-Ar?

CIWA-Ar stands for Clinical Institute Withdrawal Assessment for Alcohol, Revised. It is a tool used by clinicians to measure withdrawal severity.

CIWA-Ar looks at signs such as:

  • Nausea and vomiting
  • Tremors
  • Sweating
  • Anxiety
  • Agitation
  • Sensory disturbances
  • Headache
  • Orientation
  • Hallucination-related symptoms

A higher score usually means more severe withdrawal. In some settings, clinicians repeat the assessment regularly to decide whether a person needs medication, another dose or a higher level of monitoring (ASAM, 2020).

CIWA-Ar is not something people should use to self-treat at home. It is most useful when combined with clinical judgment, vital signs and knowledge of the person’s health history.

How Long It Is Usually Used

Librium is usually used during the acute withdrawal period, which often lasts several days. Many people have the most intense symptoms within the first few days after their last drink, but the timeline can vary.

A general timeline may look like this:

  • 6 to 12 hours after the last drink: anxiety, tremors, sweating, nausea, headache or insomnia may begin
  • 12 to 24 hours: symptoms may become more noticeable, and some people may experience hallucinations
  • 24 to 48 hours: seizure risk may increase in some people
  • 48 to 72 hours: delirium tremens may develop in high-risk cases
  • 3 to 5 days: many acute symptoms begin improving, although some symptoms may last longer

This timeline can vary. A clinical review notes that acute symptomatic seizures may occur 6–48 hours after the last drink and that delirium tremens often begins 48–72 hours after cessation (Jesse et al., 2016).

The length of use depends on the person’s response. Some people need only short-term symptom management, while others need a tapering schedule to prevent rebound symptoms or benzodiazepine withdrawal.

Can You Take It at Home?

Some people may be treated in an outpatient setting, but this should only happen when a clinician determines it is safe. At-home alcohol withdrawal can be risky because symptoms can worsen quickly.

Outpatient management may not be appropriate for people who:

  • Have a history of withdrawal seizures
  • Have had delirium tremens before
  • Drink heavily every day
  • Have severe symptoms
  • Have unstable housing or limited support
  • Use opioids, benzodiazepines or other sedatives
  • Have serious heart, liver or neurological conditions
  • Are at risk of self-harm
  • Cannot attend frequent follow-up visits
  • May continue drinking while taking the medication

ASAM guidance emphasizes matching care to the patient’s risk level and monitoring needs, which is why inpatient support may be safer for higher-risk withdrawal (ASAM, 2020).

What Happens During Medical Detox?

During detox, clinicians monitor withdrawal symptoms and decide whether Librium or another option is appropriate. The goal is to reduce discomfort, prevent complications and help the person stabilize.

Supervised care may include:

  • Withdrawal assessment
  • Vital sign monitoring
  • CIWA-Ar scoring or another symptom scale
  • Librium or another withdrawal medication when appropriate
  • Seizure and delirium tremens monitoring
  • Hydration and nutrition support
  • Vitamin supplementation when appropriate
  • Sleep support
  • Mental health screening
  • Medication review
  • Planning for ongoing treatment

Detox is focused on stabilization. It is not the same as complete addiction treatment. SAMHSA describes substance use treatment as a broader process that may include medications, behavioral therapies and recovery support after stabilization (SAMHSA, 2025).

Risks and Side Effects

Librium can be helpful, but it also has risks. The most common side effects are related to sedation and slowed central nervous system activity.

Possible side effects include:

  • Drowsiness
  • Dizziness
  • Confusion
  • Poor coordination
  • Slowed reaction time
  • Weakness
  • Fatigue
  • Nausea
  • Constipation
  • Changes in libido
  • Rash
  • Swelling
  • Fainting

Older adults may be more sensitive to sedation, confusion and falls. People with liver disease may also need a different approach because some medications can build up in the body (Ahwazi et al., 2024).

A person taking Librium should not drive, operate machinery or make important decisions if they feel sedated, confused or impaired. DailyMed advises patients not to drive or operate machinery until they know how chlordiazepoxide affects them (U.S. National Library of Medicine, 2025). Mayo Clinic also warns that chlordiazepoxide may cause dizziness, drowsiness or reduced alertness, which can make driving unsafe (Mayo Clinic, n.d.).

Why Mixing It With Alcohol Is Dangerous

Mixing Librium with alcohol is dangerous because both substances slow the central nervous system. Together, they can cause stronger sedation than either substance alone. DailyMed warns that alcohol should generally not be used during benzodiazepine treatment because it can intensify sedative effects (U.S. National Library of Medicine, 2025).

Combining the two may increase the risk of:

  • Severe drowsiness
  • Confusion
  • Falls or injuries
  • Blackouts
  • Slowed breathing
  • Vomiting while sedated
  • Loss of consciousness
  • Overdose
  • Death

This is one reason care should be supervised. If a person continues drinking while taking the medication, it can become dangerous instead of protective.

Opioids and Other Sedatives

Librium can also be dangerous when combined with opioids, sleeping pills, muscle relaxers, other benzodiazepines or sedating medications. DailyMed warns that benzodiazepines and opioids used together can cause profound sedation, respiratory depression, coma and death (U.S. National Library of Medicine, 2025).

Before taking it, a person should tell their care team about all substances and medications they use, including:

  • Alcohol
  • Opioids
  • Benzodiazepines
  • Sleep medications
  • Muscle relaxers
  • Antidepressants
  • Antipsychotics
  • Seizure medications
  • Over-the-counter sleep aids
  • Herbal supplements
  • Non-prescribed drugs

Honest reporting helps the care team choose the safest plan.

Who Needs Closer Monitoring?

Some people need closer monitoring when taking Librium. Clinicians may use a different medication or a higher level of care when risk factors are present.

Closer monitoring may be needed for patients who:

  • Are older adults
  • Have liver disease
  • Have breathing problems
  • Have a seizure history
  • Have had delirium tremens before
  • Use opioids or sedatives
  • Have severe symptoms
  • Have suicidal thoughts
  • Are pregnant
  • Have unstable vital signs
  • Have co-occurring mental health symptoms
  • Have a history of benzodiazepine dependence

The safest plan depends on the full health picture, not just the number of drinks someone had. ASAM emphasizes that care planning should account for medical, psychiatric and withdrawal-risk factors when determining setting and monitoring needs (ASAM, 2020).

Dependence and Addiction Risk

Librium can be habit-forming because it is a benzodiazepine. Dependence can develop when benzodiazepines are taken regularly, especially for longer periods or at higher amounts. This is why clinicians usually use it for a short period and monitor dosing carefully (U.S. National Library of Medicine, 2025).

Benzodiazepine dependence is different from alcohol withdrawal treatment. When used appropriately in a stabilization setting, the goal is to steady the person and then reduce or stop the medication as soon as it is safe.

A person should not continue taking it longer than prescribed or use someone else’s medication. Misuse can lead to dependence, withdrawal, overdose or relapse risk.

Comparing Detox Medications

Librium is one of several medications that may be used during alcohol withdrawal. Other benzodiazepines, such as diazepam or lorazepam, may also be used depending on the person’s symptoms, age, liver function, health history and care setting.

Librium may be selected because it is long-acting, which can help provide smoother symptom control for some people. Lorazepam may be preferred in certain cases, such as when liver function is a concern, because clinicians may choose medications based on how they are processed by the body. ASAM notes that medication choice should consider patient factors such as age, liver disease and risk of accumulation (ASAM, 2020).

The best option is not the same for everyone. A provider should choose the safest medication based on severity, health history and complication risk.

Does Detox Medication Treat Addiction?

Librium treats withdrawal symptoms, but it does not treat alcohol use disorder by itself. Stabilization is the first step for many people, but recovery often requires ongoing support after symptoms improve.

Addiction treatment may include:

  • Medical detox
  • Residential treatment
  • Rehab
  • Partial hospitalization programming
  • Intensive outpatient programming
  • Outpatient treatment
  • Individual therapy
  • Group therapy
  • Medication-assisted treatment
  • Relapse prevention planning
  • Family therapy
  • Mental health care
  • Peer support or recovery meetings
  • Aftercare planning

Without follow-up care, a person may return to alcohol use. A complete recovery plan should address cravings, triggers, health concerns, relationships, stress, sleep and relapse prevention. SAMHSA describes treatment for substance use disorders as including medications, behavioral therapies and continuing support (SAMHSA, 2025).

Medications After Detox

After withdrawal is stabilized, some people may benefit from medications that help reduce cravings or support ongoing recovery. Librium is not usually used for long-term addiction treatment, but other medications may be considered.

Medications for alcohol use disorder may include:

  • Naltrexone
  • Acamprosate
  • Disulfiram

NIAAA lists disulfiram, naltrexone and acamprosate as FDA-approved medications for this condition, often used along with behavioral treatment or recovery support (NIAAA, n.d.).

These medications are not right for everyone. A clinician can help decide whether medication-assisted treatment is appropriate based on liver health, opioid use, cravings, relapse history and goals.

Safe and Effective Medical Detox in Washington State

Going through alcohol withdrawal on your own is not only uncomfortable; it can also be very dangerous. Complications like seizures and delirium tremens are considered a medical emergency and require professional intervention. Fortunately, medical detox centers that provide round-the-clock expert care, like The Recovery Village Ridgefield, can help. We offer a full continuum of care, not only weaning you from alcohol in our state-of-the-art facility but easing your way into rehab to support your long-term sobriety. If you or a loved one struggle with alcohol, don’t wait — contact a Recovery Advocate today to see how we can help.

Insurance May Cover The Cost of Detox

Your insurance may cover some or all of the cost of addiction treatment. Our online health insurance verification system will estimate your in-network and out-of-network deductibles, coinsurance percentages and out-of-pocket maximums. Within 5 minutes, you’ll receive an email with these details – free of charge. Fill out the form below to get started:

[contact-form-7 id=”c47ac79″ title=”Admission Insurance (NEW)”]

Frequently Asked Questions

What does Librium do during detox?

Librium helps calm overactive brain and nervous system activity during alcohol withdrawal. It may reduce symptoms such as anxiety, tremors, agitation and insomnia while helping lower the risk of seizures or delirium tremens.

Is it the same as the generic medication?

Yes. Librium is the brand name commonly associated with chlordiazepoxide. Many people still use the name Librium even when referring to generic chlordiazepoxide.

How fast can it start working?

It can begin working within a few hours, but the exact timing depends on the dose, metabolism, symptom severity and whether other substances are involved.

How many days is it usually taken?

It is usually used short term during the acute withdrawal period, often for several days. Some people may need a taper depending on symptoms, dose and medical risk factors.

Can you drink while taking it?

No. Drinking while taking this medication can be dangerous and may increase the risk of severe sedation, slowed breathing, overdose, loss of consciousness and death.

Can it help prevent seizures?

It may help reduce seizure risk during alcohol withdrawal when used appropriately under medical supervision. People with a history of withdrawal seizures should seek monitored care instead of trying to withdraw at home.

Is at-home detox safe?

At-home detox is only appropriate for some low-risk people and should be decided by a clinician. People with severe symptoms, seizure history, delirium tremens history, heavy daily use, unstable health or polysubstance use usually need closer monitoring.

What is CIWA-Ar?

CIWA-Ar is a clinical tool used to rate withdrawal severity. Care teams may use it to decide when medication is needed and how closely someone should be monitored.

Can it be habit-forming?

Yes, this medication can be habit-forming if used for too long, taken in high amounts or misused. In supervised care, it is typically used for a short period.

What comes after detox?

After withdrawal is stabilized, ongoing addiction treatment may include therapy, relapse prevention, medication-assisted treatment, mental health care, group support, rehab and aftercare planning.

Is another benzodiazepine sometimes safer?

Yes. This medication may be useful because it is long-acting, but lorazepam or another option may be safer for some people, especially when certain health conditions are present. A clinician should choose the medication based on withdrawal risk and health history.

References

Ahwazi, H. H., McKenzie, C., & Lai, B. (2024). Chlordiazepoxide. StatPearls Publishing.
Full link: https://www.ncbi.nlm.nih.gov/books/NBK547659/

American Society of Addiction Medicine. (2020). The ASAM clinical practice guideline on alcohol withdrawal management.
Full link: https://www.asam.org/docs/default-source/quality-science/the_asam_clinical_practice_guideline_on_alcohol-1.pdf

Canver, B. R., Rehm, J., & DiClemente, C. C. (2024). Alcohol withdrawal syndrome. StatPearls Publishing.
Full link: https://www.ncbi.nlm.nih.gov/books/NBK441882/

Dharavath, R. N., Shetty, R. A., & Thirthalli, J. (2023). GABAergic signaling in alcohol use disorder and withdrawal. Frontiers in Cellular Neuroscience, 17, 1249598.
Full link: https://pmc.ncbi.nlm.nih.gov/articles/PMC10623140/

Jesse, S., Bråthen, G., Ferrara, M., Keindl, M., Ben-Menachem, E., Tanasescu, R., Brodtkorb, E., Hillbom, M., Leone, M. A., & Ludolph, A. C. (2016). Alcohol withdrawal syndrome: Mechanisms, manifestations, and management. Acta Neurologica Scandinavica, 135(1), 4–16.
Full link: https://pmc.ncbi.nlm.nih.gov/articles/PMC6084325/

Kaye, A. D., et al. (2024). Delirium tremens: A review of clinical studies. Cureus, 16(4), e58915.
Full link: https://pmc.ncbi.nlm.nih.gov/articles/PMC11069634/

Mayo Clinic. (n.d.). Chlordiazepoxide hydrochloride (oral route): Precautions.
Full link: https://www.mayoclinic.org/drugs-supplements/chlordiazepoxide-hydrochloride-oral-route/precautions/drg-20072246

National Institute on Alcohol Abuse and Alcoholism. (n.d.). Medications development program.
Full link: https://www.niaaa.nih.gov/medications-development-program

Substance Abuse and Mental Health Services Administration. (2025). Treatment options for substance use disorder.
Full link: https://www.samhsa.gov/substance-use/treatment/options

U.S. National Library of Medicine. (2025). Chlordiazepoxide hydrochloride capsule: Drug label information. DailyMed.
Full link: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3cbd7cee-c4d7-4c95-93d8-09428169b937